{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:55:18Z","timestamp":1789095318517,"version":"build-2803163510"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007497","name":"Biosense Webster Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cardiovascular Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Ventricular tachyarrhythmias (VT\/VF) are common among patients with prior myocardial infarction (MI). MANTRA-VT trial was designed to compare the efficacy and safety of early substrate-based radiofrequency catheter ablation (RFCA) to antiarrhythmic drug (AAD) therapy for ventricular tachyarrhythmias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We randomly assigned 58 AAD na\u00efve post MI patients with implantable cardioverter defibrillator (ICD) and at least one documented VT\/VF episode after the device implantation to an initial treatment strategy of substrate-based RFCA or AAD therapy. The primary endpoint was cumulative number of ventricular tachyarrhythmias (VT\/VF burden) at 12 months. The secondary endpoints included all-cause mortality, hospitalization, adverse events, and VT\/VF burden at 24 months. Analyses were performed on an intention-to-treat basis. The median number of VT\/VF episodes at 12 months was zero in both the RFCA (range 0\u20133) and the AAD group (range 0\u201323) (P = 0.454), whereas the rate of appropriate ICD shocks was 7% and 30% in the RFCA and the AAD groups (P = 0.026), respectively. During the extended follow-up, 82% of the patients in the RFCA group and 63% in the AAD group had no ICD therapies (P = 0.012). There was no significant difference between the groups in total mortality (HR 1.02, 95% CI 0.20\u20135.11, P = 0.86) and hospitalization (HR 1.35, 95% CI 0.36\u20135.09. P = 0.66) at 24 months. Therapy-related adverse events occurred in 3.6% and 16.7% of the patients in the RFCA and the AAD groups (P = 0.10), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early substrate-based RFCA was associated with reduced risk of ICD therapies, but with no meaningful difference in VT\/VF burden, mortality, hospitalization, and adverse events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euaf236","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T11:35:49Z","timestamp":1759750549000},"source":"Crossref","is-referenced-by-count":7,"title":["Early substrate-based catheter ablation vs. antiarrhythmic drug therapy for ventricular tachyarrhythmias among patients with prior myocardial infarction: the MANTRA-VT randomized trial"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3502-8789","authenticated-orcid":false,"given":"Pekka","family":"Raatikainen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Heart and Lung Center, Helsinki University Hospital and University of Helsinki , Haartmaninkatu 4, Helsinki 00290 ,","place":["Finland"]},{"name":"Department of Internal Medicine, Central Finland Central Hospital , Jyv\u00e4skyl\u00e4 ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3324-5073","authenticated-orcid":false,"given":"Heikki","family":"M\u00e4kynen","sequence":"additional","affiliation":[{"name":"Heart Hospital Tampere University Hospital , Tampere ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0847-107X","authenticated-orcid":false,"given":"Juha","family":"Hartikainen","sequence":"additional","affiliation":[{"name":"Heart Center, Kuopio University Hospital , Kuopio ,","place":["Finland"]},{"name":"University of Eastern Finland , Kuopio ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2727-3493","authenticated-orcid":false,"given":"Mats Jensen","family":"Urstad","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Karolinska University Hospital, Stockholm ,","place":["Sweden"]},{"name":"Department of Medicine, Karolinska Institute , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Konkola","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Central Finland Central Hospital , Jyv\u00e4skyl\u00e4 ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2876-7388","authenticated-orcid":false,"given":"Niels C F","family":"Sandgaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4584-6184","authenticated-orcid":false,"given":"Peter","family":"Lukac","sequence":"additional","affiliation":[{"name":"Deparment of Cardiology, Aarhus University Hospital , Aarhus ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0294-3750","authenticated-orcid":false,"given":"Arne","family":"Johannessen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Gentofte Hospital, Copenhagen University Hospital , Gentofte ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"J\u00f6nsson","sequence":"additional","affiliation":[{"name":"University of Link\u00f6ping , Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4792-197X","authenticated-orcid":false,"given":"Peter","family":"Schuster","sequence":"additional","affiliation":[{"name":"Department of Heart Disease, Haukeland University Hospital , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2806-3903","authenticated-orcid":false,"given":"Carina","family":"Blomstr\u00f6m-Lundqvist","sequence":"additional","affiliation":[{"name":"Department of Cardiology, School of Medical Sciences, Faculty of Medicine and Health, \u00d6rebro University , \u00d6rebro, Sweden"},{"name":"Department of Medical Science, Uppsala University Hospital , Uppsala ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5924-0808","authenticated-orcid":false,"given":"Jussi","family":"Kuutti","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart and Lung Center, Helsinki University Hospital and University of Helsinki , Haartmaninkatu 4, Helsinki 00290 ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3560-8860","authenticated-orcid":false,"given":"Piia","family":"Lavikainen","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , Kuopio ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Parikka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart and Lung Center, Helsinki University Hospital and University of Helsinki , Haartmaninkatu 4, Helsinki 00290 ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"2025101516282105400_euaf236-B1","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"},{"key":"2025101516282105400_euaf236-B2","doi-asserted-by":"crossref","first-page":"euad091","DOI":"10.1093\/europace\/euad091","article-title":"Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects","volume":"25","author":"K\u00f6nemann","year":"2023","journal-title":"Europace"},{"key":"2025101516282105400_euaf236-B3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ijcard.2014.09.170","article-title":"Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy: a systematic review","volume":"177","author":"Gracieux","year":"2014","journal-title":"Int J Cardiol"},{"key":"2025101516282105400_euaf236-B4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.hrthm.2021.10.010","article-title":"Trends in implantable cardioverter-defibrillator programming practices and its impact on therapies: insights from a North American remote monitoring registry 2007\u20132018","volume":"19","author":"Bennett","year":"2022","journal-title":"Heart Rhythm"},{"key":"2025101516282105400_euaf236-B5","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2025101516282105400_euaf236-B6","doi-asserted-by":"crossref","first-page":"104521","DOI":"10.1016\/j.phrs.2019.104521","article-title":"The role of amiodarone in contemporary management of complex cardiac arrhythmias","volume":"151","author":"Mujovi\u0107","year":"2020","journal-title":"Pharmacol Res"},{"key":"2025101516282105400_euaf236-B7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"2025101516282105400_euaf236-B8","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.31083\/j.rcm2204143","article-title":"Amiodarone in ventricular arrhythmias: still a valuable resource?","volume":"22","author":"Pannone","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"2025101516282105400_euaf236-B9","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/europace\/euq316","article-title":"Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management","volume":"12","author":"Braunschweig","year":"2010","journal-title":"Europace"},{"key":"2025101516282105400_euaf236-B10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/europace\/euz132","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias","volume":"21","author":"Cronin","year":"2019","journal-title":"Europace"},{"key":"2025101516282105400_euaf236-B11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet"},{"key":"2025101516282105400_euaf236-B12","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N Engl J Med"},{"key":"2025101516282105400_euaf236-B13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/CIRCULATIONAHA.106.686534","article-title":"Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study","volume":"117","author":"Carbucicchio","year":"2008","journal-title":"Circulation"},{"key":"2025101516282105400_euaf236-B14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10840-010-9469-5","article-title":"Endocardial and epicardial mapping and catheter ablation of post myocardial infarction ventricular tachycardia: a substrate modification approach","volume":"28","author":"Arruda","year":"2010","journal-title":"J Interv Card Electrophysiol"},{"key":"2025101516282105400_euaf236-B15","doi-asserted-by":"crossref","first-page":"euae049","DOI":"10.1093\/europace\/euae049","article-title":"Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC-endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society","volume":"26","author":"Lenarczyk","year":"2024","journal-title":"Europace"},{"key":"2025101516282105400_euaf236-B16","doi-asserted-by":"crossref","first-page":"euaf055","DOI":"10.1093\/europace\/euaf055","article-title":"Epicardial ventricular arrhythmia ablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society","volume":"27","author":"Arya","year":"2025","journal-title":"Europace"},{"key":"2025101516282105400_euaf236-B17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/europace\/euac151","article-title":"Contemporary management of ventricular electrical storm in Europe: results of a European Heart Rhythm Association Survey","volume":"25","author":"Baldi","year":"2023","journal-title":"Europace"},{"key":"2025101516282105400_euaf236-B18","doi-asserted-by":"crossref","first-page":"euad225","DOI":"10.1093\/europace\/euad225","article-title":"Twenty-five years of catheter ablation of ventricular tachycardia: a look back and a look forward","volume":"25","author":"Natale","year":"2023","journal-title":"Europace"},{"key":"2025101516282105400_euaf236-B19","doi-asserted-by":"crossref","first-page":"e004422","DOI":"10.1161\/CIRCEP.116.004422","article-title":"Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (substrate modification study)","volume":"10","author":"Kuck","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025101516282105400_euaf236-B20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","article-title":"Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial","volume":"141","author":"Willems","year":"2020","journal-title":"Circulation"},{"key":"2025101516282105400_euaf236-B21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"key":"2025101516282105400_euaf236-B22","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598","article-title":"Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial","volume":"145","author":"Della Bella","year":"2022","journal-title":"Circulation"},{"key":"2025101516282105400_euaf236-B23","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/CIRCULATIONAHA.122.060039","article-title":"First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial","volume":"145","author":"Tung","year":"2022","journal-title":"Circulation"},{"key":"2025101516282105400_euaf236-B24","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2022.01.050","article-title":"Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia","volume":"79","author":"Arenal","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025101516282105400_euaf236-B25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa2409501","article-title":"Catheter ablation or antiarrhythmic drugs for ventricular tachycardia","volume":"392","author":"Sapp","year":"2024","journal-title":"N Engl J Med"},{"key":"2025101516282105400_euaf236-B26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ahj.2017.03.009","article-title":"Effects of implantable cardioverter\/defibrillator shock and antitachycardia pacing on anxiety and quality of life: a MADIT-RIT substudy","volume":"189","author":"Perini","year":"2017","journal-title":"Am Heart J"},{"key":"2025101516282105400_euaf236-B27","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2013.04.083","article-title":"Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study","volume":"62","author":"Powell","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025101516282105400_euaf236-B28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000529670","article-title":"Pharmacotherapy in ventricular arrhythmias","volume":"148","author":"Apte","year":"2023","journal-title":"Cardiology"},{"key":"2025101516282105400_euaf236-B29","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jacep.2023.01.030","article-title":"Ventricular tachycardia and ICD therapy burden with catheter ablation versus escalated antiarrhythmic drug therapy","volume":"9","author":"Samuel","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2025101516282105400_euaf236-B30","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.hrthm.2022.07.005","article-title":"Impact of early ventricular tachycardia ablation in patients with an implantable cardioverter-defibrillator: an updated systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Prasitlumkum","year":"2022","journal-title":"Heart Rhythm"},{"key":"2025101516282105400_euaf236-B31","doi-asserted-by":"crossref","first-page":"e007600","DOI":"10.1161\/CIRCEP.119.007600","article-title":"Antiarrhythmic drugs or catheter ablation in the management of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Kheiri","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025101516282105400_euaf236-B32","doi-asserted-by":"crossref","first-page":"euae109","DOI":"10.1093\/europace\/euae109","article-title":"Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion","volume":"26","author":"\u017di\u017eek","year":"2024","journal-title":"Europace"},{"key":"2025101516282105400_euaf236-B33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10840-016-0217-3","article-title":"MAGNETIC VT study: a prospective, multicenter, post-market randomized controlled trial comparing VT ablation outcomes using remote magnetic navigation-guided substrate mapping and ablation versus manual approach in a low LVEF population","volume":"48","author":"Di Biase","year":"2017","journal-title":"J Interv Card Electrophysiol"},{"key":"2025101516282105400_euaf236-B34","doi-asserted-by":"crossref","first-page":"euad361","DOI":"10.1093\/europace\/euad361","article-title":"Major in-hospital complications after catheter ablation of cardiac arrhythmias: individual case analysis of 43 031 procedures","volume":"26","author":"Eckardt","year":"2023","journal-title":"Europace"},{"key":"2025101516282105400_euaf236-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2024.04.009","article-title":"A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: the VANISH2 trial","volume":"274","author":"Sapp","year":"2024","journal-title":"Am Heart J"},{"key":"2025101516282105400_euaf236-B36","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.hrthm.2022.07.024","article-title":"Early ventricular tachycardia ablation: for some, but not for all?","volume":"19","author":"Mirwais","year":"2022","journal-title":"Heart Rhythm"},{"key":"2025101516282105400_euaf236-B37","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.3390\/jcm13175017","article-title":"Approaching ventricular tachycardia ablation in 2024: an update on mapping and ablation strategies, timing, and future directions","volume":"13","author":"Di Cori","year":"2024","journal-title":"J Clin Med"},{"key":"2025101516282105400_euaf236-B38","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.15420\/aer.2024.39","article-title":"Functional substrate mapping: a new frontier in the treatment of ventricular tachycardia in structural heart disease","volume":"13","author":"Al-Sheikhli","year":"2024","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2025101516282105400_euaf236-B39","doi-asserted-by":"crossref","first-page":"euaf003","DOI":"10.1093\/europace\/euaf003","article-title":"Evoked delayed potential ablation for post-myocardial infarction ventricular tachycardia: results from a large prospective multicentre study","volume":"27","author":"de Riva","year":"2025","journal-title":"Europace"},{"key":"2025101516282105400_euaf236-B40","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.3390\/jcm12216798","article-title":"Current role of SLGT2 inhibitors in the management of the whole spectrum of heart failure: focus on dapagliflozin","volume":"12","author":"Escobar","year":"2023","journal-title":"J Clin Med"},{"key":"2025101516282105400_euaf236-B41","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/eurheartj\/ehab560","article-title":"Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF","volume":"42","author":"Curtain","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/10\/euaf236\/64712113\/euaf236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/10\/euaf236\/64712113\/euaf236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T20:28:31Z","timestamp":1760560111000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euaf236\/8286994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,7]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaf236","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,10]]},"article-number":"euaf236"}}